Surgical site infection following abdominal surgery: A randomized control trial comparing common dressing and antimicorobial dressing containing ionic silver (Aquacel Ag Hydrofiber)
Not Applicable
- Conditions
- Patients undergoing abdominal digestive surgery
- Registration Number
- JPRN-UMIN000043081
- Lead Sponsor
- Department of Surgery, Teikyo University Chiba Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Not provided
Exclusion Criteria
patients with the following levels of bone marrow, hepatic, and renal function based on the data obtained within 1 week before enrollment. 1)white blood cell count <4,000/mm3 and >12,000mm3 2)platelet count <100,000mm3 3)hemoglobin <9.0 g/dL 4)total bilirubin >2.0 mg/dL, asparate aminotransferase (AST) / glutamate oxaloacetate transaminase (GOT) > 100 IU/L, alanine aminotransferase (AST) / glutamate pyruvate transaminase (GPT) >100 IU/L 5)serum creatinine below the institutional upper limit of normal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method